| Erin Christina Egan, LMSW | |
|
2500 Packard St Ste 104a, Ann Arbor, MI 48104-6827 | |
| (734) 707-1052 | |
| (734) 661-1887 |
| Full Name | Erin Christina Egan |
|---|---|
| Gender | Female |
| Speciality | Clinical Social Worker |
| Experience | 19 Years |
| Location | 2500 Packard St Ste 104a, Ann Arbor, Michigan |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023222023 | NPI | - | NPPES |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| W.a. Foote Memorial Hospital, Inc. | 0244136067 | 435 |
News Archive
Medtronic Inc. today announced the CE mark and international launch of the Endurant II AAA Stent Graft System, which meaningfully expands the options physicians outside the United States have to treat patients with abdominal aortic aneurysms through a minimally invasive technique called endovascular aortic repair.
University of Utah scientists have taken significant steps to fight a deadly childhood muscle cancer by identifying some of the genetic events that cause the disease and then engineering mice that develop the tumors.
A new study published online today by JAMA shows that among patients age 65 years and older, rosiglitazone (a medication for treating Type 2 diabetes) is associated with an increased risk of stroke, heart failure, and all-cause mortality (death) when compared with pioglitazone (another medication for diabetes). The study was published online today in advance of an upcoming Food and Drug Administration meeting that will review the safety of rosiglitazone. The paper will appear in the July 28 print issue of JAMA.
Worldwide, more than 1.2 million traffic fatalities occur yearly, and the lives of pedestrians account for a third of those lost. In the United States, pedestrians make up 12 percent of deaths from traffic collisions. According to a newly published study, male pedestrians struck by vehicles are more than twice as likely to die as their female counterparts.
› Verified 6 days ago
| Entity Name | W.a. Foote Memorial Hospital, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326078866 PECOS PAC ID: 0244136067 Enrollment ID: O20031215000361 |
News Archive
Medtronic Inc. today announced the CE mark and international launch of the Endurant II AAA Stent Graft System, which meaningfully expands the options physicians outside the United States have to treat patients with abdominal aortic aneurysms through a minimally invasive technique called endovascular aortic repair.
University of Utah scientists have taken significant steps to fight a deadly childhood muscle cancer by identifying some of the genetic events that cause the disease and then engineering mice that develop the tumors.
A new study published online today by JAMA shows that among patients age 65 years and older, rosiglitazone (a medication for treating Type 2 diabetes) is associated with an increased risk of stroke, heart failure, and all-cause mortality (death) when compared with pioglitazone (another medication for diabetes). The study was published online today in advance of an upcoming Food and Drug Administration meeting that will review the safety of rosiglitazone. The paper will appear in the July 28 print issue of JAMA.
Worldwide, more than 1.2 million traffic fatalities occur yearly, and the lives of pedestrians account for a third of those lost. In the United States, pedestrians make up 12 percent of deaths from traffic collisions. According to a newly published study, male pedestrians struck by vehicles are more than twice as likely to die as their female counterparts.
› Verified 6 days ago
| Entity Name | Catholic Charities Of Jackson Lenawee And Hillsdale Counties |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689628190 PECOS PAC ID: 5597781385 Enrollment ID: O20051020000792 |
News Archive
Medtronic Inc. today announced the CE mark and international launch of the Endurant II AAA Stent Graft System, which meaningfully expands the options physicians outside the United States have to treat patients with abdominal aortic aneurysms through a minimally invasive technique called endovascular aortic repair.
University of Utah scientists have taken significant steps to fight a deadly childhood muscle cancer by identifying some of the genetic events that cause the disease and then engineering mice that develop the tumors.
A new study published online today by JAMA shows that among patients age 65 years and older, rosiglitazone (a medication for treating Type 2 diabetes) is associated with an increased risk of stroke, heart failure, and all-cause mortality (death) when compared with pioglitazone (another medication for diabetes). The study was published online today in advance of an upcoming Food and Drug Administration meeting that will review the safety of rosiglitazone. The paper will appear in the July 28 print issue of JAMA.
Worldwide, more than 1.2 million traffic fatalities occur yearly, and the lives of pedestrians account for a third of those lost. In the United States, pedestrians make up 12 percent of deaths from traffic collisions. According to a newly published study, male pedestrians struck by vehicles are more than twice as likely to die as their female counterparts.
› Verified 6 days ago
| Entity Name | Integrative Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275085375 PECOS PAC ID: 5092081687 Enrollment ID: O20171026001459 |
News Archive
Medtronic Inc. today announced the CE mark and international launch of the Endurant II AAA Stent Graft System, which meaningfully expands the options physicians outside the United States have to treat patients with abdominal aortic aneurysms through a minimally invasive technique called endovascular aortic repair.
University of Utah scientists have taken significant steps to fight a deadly childhood muscle cancer by identifying some of the genetic events that cause the disease and then engineering mice that develop the tumors.
A new study published online today by JAMA shows that among patients age 65 years and older, rosiglitazone (a medication for treating Type 2 diabetes) is associated with an increased risk of stroke, heart failure, and all-cause mortality (death) when compared with pioglitazone (another medication for diabetes). The study was published online today in advance of an upcoming Food and Drug Administration meeting that will review the safety of rosiglitazone. The paper will appear in the July 28 print issue of JAMA.
Worldwide, more than 1.2 million traffic fatalities occur yearly, and the lives of pedestrians account for a third of those lost. In the United States, pedestrians make up 12 percent of deaths from traffic collisions. According to a newly published study, male pedestrians struck by vehicles are more than twice as likely to die as their female counterparts.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Erin Christina Egan, LMSW 548 S Main St, Ann Arbor, MI 48104-2921 Ph: () - | Erin Christina Egan, LMSW 2500 Packard St Ste 104a, Ann Arbor, MI 48104-6827 Ph: (734) 707-1052 |
News Archive
Medtronic Inc. today announced the CE mark and international launch of the Endurant II AAA Stent Graft System, which meaningfully expands the options physicians outside the United States have to treat patients with abdominal aortic aneurysms through a minimally invasive technique called endovascular aortic repair.
University of Utah scientists have taken significant steps to fight a deadly childhood muscle cancer by identifying some of the genetic events that cause the disease and then engineering mice that develop the tumors.
A new study published online today by JAMA shows that among patients age 65 years and older, rosiglitazone (a medication for treating Type 2 diabetes) is associated with an increased risk of stroke, heart failure, and all-cause mortality (death) when compared with pioglitazone (another medication for diabetes). The study was published online today in advance of an upcoming Food and Drug Administration meeting that will review the safety of rosiglitazone. The paper will appear in the July 28 print issue of JAMA.
Worldwide, more than 1.2 million traffic fatalities occur yearly, and the lives of pedestrians account for a third of those lost. In the United States, pedestrians make up 12 percent of deaths from traffic collisions. According to a newly published study, male pedestrians struck by vehicles are more than twice as likely to die as their female counterparts.
› Verified 6 days ago